SB 2443 Hawaii Senate · 2020 Regular Session

RELATING TO PRESCRIPTION INSULIN DRUGS.

Summary
Requires insurers, mutual benefit societies, and health maintenance organizations that provide coverage for prescription insulin drugs to cap the total amount the policyholder, member, or subscriber is required to pay at an amount not to exceed $100 per thirty-day supply of insulin, beginning 1/1/2021. Requires the insurance commissioner with the assistance of the attorney general to investigate prescription insulin drug pricing and submit a report to the legislature, governor, and general public. Appropriates funds.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2020
Committee Review
Floor Vote
Governor
Introduced Jan 17, 2020 Last action Jan 23, 2020
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
0
Committee
1
Jan 23, 2020
Senate · Referred to committee
Referred to CPH/JDC, WAM.
Jan 17, 2020
Senate · Introduced
Introduced.
3 primary · 0 co-sponsors

Sponsors